Clinical Trial Update: Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of EPA (eicosapentaenoic acid) in men with biochemical recurrence or progression of prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Eicosapentaenoic acid (EPA) (eicosapentaenoic acid)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING